Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D J Padley

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Clinical Pharmacology and Therapeutics|July 20, 2007
Infrastructure development for human cell therapy translationA B Dietz, D J Padley, D A Gastineau
Journal of Hematotherapy & Stem Cell Research|July 17, 2001
Mature myeloid dendritic cells for clinical use prepared from CD14+ cells isolated by immunomagnetic adsorptionD J Padley, A B Dietz, D A Gastineau, et al.
Vox Sanguinis|October 13, 2011
Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assaysS A Baylis, L Ma, D J Padley, et al.
Cytotherapy|May 29, 2003
Endogenous microbial contamination of cultured autologous preparations in trials of cancer immunotherapyD J Padley, C W Greiner, T L Heddlesten, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Organ procurement organization compliance with 21 CFR 1271: a challenge for allogeneic pancreatic islet cell transplantation programsJ L Winters, S A Tran, D A Gastineau, et al.
Cytotherapy|March 19, 2005
Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanomaA B Dietz, D J Padley, G W Butler, et al.
Bone Marrow Transplantation|March 15, 2006
Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection targetR Katipamula, L F Porrata, D A Gastineau, et al.
Cytotherapy|June 24, 2006
Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CMLM R Litzow, A B Dietz, P A Bulur, et al.
Bone Marrow Transplantation|December 17, 2003
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphomaL F Porrata, M R Litzow, D J Inwards, et al.
Leukemia|March 26, 2004
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myelomaL F Porrata, M A Gertz, S M Geyer, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Clinical Pharmacology and Therapeutics|July 20, 2007
Infrastructure development for human cell therapy translationA B Dietz, D J Padley, D A Gastineau
Journal of Hematotherapy & Stem Cell Research|July 17, 2001
Mature myeloid dendritic cells for clinical use prepared from CD14+ cells isolated by immunomagnetic adsorptionD J Padley, A B Dietz, D A Gastineau, et al.
Vox Sanguinis|October 13, 2011
Collaborative study to establish a World Health Organization International genotype panel for parvovirus B19 DNA nucleic acid amplification technology (NAT)-based assaysS A Baylis, L Ma, D J Padley, et al.
Cytotherapy|May 29, 2003
Endogenous microbial contamination of cultured autologous preparations in trials of cancer immunotherapyD J Padley, C W Greiner, T L Heddlesten, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 23, 2009
Organ procurement organization compliance with 21 CFR 1271: a challenge for allogeneic pancreatic islet cell transplantation programsJ L Winters, S A Tran, D A Gastineau, et al.
Cytotherapy|March 19, 2005
Clinical-grade manufacturing of DC from CD14+ precursors: experience from phase I clinical trials in CML and malignant melanomaA B Dietz, D J Padley, G W Butler, et al.
Bone Marrow Transplantation|March 15, 2006
Apheresis instrument settings influence infused absolute lymphocyte count affecting survival following autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphoma: the need to optimize instrument setting and define a lymphocyte collection targetR Katipamula, L F Porrata, D A Gastineau, et al.
Cytotherapy|June 24, 2006
Testing the safety of clinical-grade mature autologous myeloid DC in a phase I clinical immunotherapy trial of CMLM R Litzow, A B Dietz, P A Bulur, et al.
Bone Marrow Transplantation|December 17, 2003
Infused peripheral blood autograft absolute lymphocyte count correlates with day 15 absolute lymphocyte count and clinical outcome after autologous peripheral hematopoietic stem cell transplantation in non-Hodgkin's lymphomaL F Porrata, M R Litzow, D J Inwards, et al.
Leukemia|March 26, 2004
The dose of infused lymphocytes in the autograft directly correlates with clinical outcome after autologous peripheral blood hematopoietic stem cell transplantation in multiple myelomaL F Porrata, M A Gertz, S M Geyer, et al.
Pageof 2